Tang Xiaoting, Li Hai, Deng Guohong, Zheng Xin, Wang Xianbo, Huang Yan, Gao Yanhang, Meng Zhongji, Qian Zhiping, Liu Feng, Lu Xiaobo, Shi Yu, Li Beiling, Gu Wenyi, Xiang Xiaomei, Xiong Yan, Hou Yixin, Chen Jun, Gao Na, Luo Sen, Ji Liujuan, Li Jing, Zheng Rongjiong, Ren Haotang, Chen Jinjun
Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Department of Gastroenterology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
J Clin Transl Hepatol. 2023 Jun 28;11(3):550-559. doi: 10.14218/JCTH.2022.00196. Epub 2022 Aug 10.
Approximately 10% of patients with acute decompensated (AD) cirrhosis develop acute-on-chronic liver failure (ACLF) within 28 days. Such cases have high mortality and are difficult to predict. Therefore, we aimed to establish and validate an algorithm to identify these patients on hospitalization.
Hospitalized patients with AD who developed ACLF within 28 days were considered pre-ACLF. Organ dysfunction was defined according to the chronic liver failure-sequential organ failure assessment (CLIF-SOFA) criteria, and proven bacterial infection was taken to indicate immune system dysfunction. A retrospective multicenter cohort and prospective one were used to derive and to validate the potential algorithm, respectively. A miss rate of <5% was acceptable for the calculating algorithm to rule out pre-ACLF.
In the derivation cohort (=673), 46 patients developed ACLF within 28 days. Serum total bilirubin, creatinine, international normalized ratio, and present proven bacterial infection at admission were associated with the development of ACLF. AD patients with ≥2 organ dysfunctions had a higher risk for pre-ACLF patients [odds ratio=16.581 95% confidence interval: (4.271-64.363), <0.001]. In the derivation cohort, 67.5% of patients (454/673) had ≤1 organ dysfunction and two patients (0.4%) were pre-ACLF, with a miss rate of 4.3% (missed/total, 2/46). In the validation cohort, 65.9% of patients (914/1388) had ≤1 organ dysfunction, and four (0.3%) of them were pre-ACLF, with a miss rate of 3.4% (missed/total, 4/117).
AD patients with ≤1 organ dysfunction had a significantly lower risk of developing ACLF within 28 days of admission and could be safely ruled out with a pre-ACLF miss rate of <5%.
约10%的急性失代偿期(AD)肝硬化患者在28天内会发展为慢加急性肝衰竭(ACLF)。此类病例死亡率高且难以预测。因此,我们旨在建立并验证一种算法,以便在患者住院时识别出这些患者。
将在28天内发展为ACLF的住院AD患者视为预ACLF患者。根据慢性肝衰竭序贯器官衰竭评估(CLIF-SOFA)标准定义器官功能障碍,确诊的细菌感染被视为免疫系统功能障碍的指标。分别采用回顾性多中心队列研究和前瞻性研究来推导和验证该潜在算法。计算算法排除预ACLF的漏诊率<5%是可接受的。
在推导队列(n = 673)中,46例患者在28天内发展为ACLF。血清总胆红素、肌酐、国际标准化比值以及入院时确诊的细菌感染与ACLF的发生相关。≥2个器官功能障碍的AD患者发生预ACLF的风险更高[比值比=16.581,95%置信区间:(4.271 - 64.363),P<0.001]。在推导队列中,67.5%的患者(454/673)存在≤1个器官功能障碍,2例患者(0.4%)为预ACLF,漏诊率为4.3%(漏诊数/总数,2/46)。在验证队列中,65.9%的患者(914/1388)存在≤1个器官功能障碍,其中4例(0.3%)为预ACLF,漏诊率为3.4%(漏诊数/总数,4/117)。
入院时存在≤1个器官功能障碍的AD患者在28天内发展为ACLF的风险显著较低,且可以以<5%的预ACLF漏诊率安全排除。